Arthritis Drug Shows Promise Against Rare Childhood Epilepsy in Largest Study Yet
A retrospective cohort study in China finds that the interleukin-6 blocker tocilizumab reduced seizures and improved disability scores in most ...
A retrospective cohort study in China finds that the interleukin-6 blocker tocilizumab reduced seizures and improved disability scores in most ...
A new perspective in Biomedical Microdevices charts nanomedicine's evolution from passive drug carriers into implantable devices, engineered cells and living ...
The FDA has cleared a CU Anschutz clinical trial testing dual-target CAR T-cell therapy against advanced colorectal cancer and pediatric ...
A dual-platform spatial transcriptomics study reveals that obesity reshapes colorectal cancer in two phases, first reprogramming healthy gut epithelium and ...
A systematic review of 542 patients finds ruxolitinib-based regimens achieve an 87.2 percent overall response rate in hemophagocytic lymphohistiocytosis, with ...
A new Nature Biomedical Engineering study maps the sequence and structural features that determine whether chimaeric antigen receptors signal effectively, ...
A new review maps how the CD73-adenosine axis drives immune suppression in non-small cell lung cancer and how blocking it ...
The inaugural Thierry de Baère Lecture maps five domains, from artificial intelligence to mentorship, that will define interventional oncology by ...
Researchers have identified ANKRD11 as a chromatin regulator whose loss reprograms CD8+ T cells to fight chronic hepatitis B and ...
New research shows that FAP-positive pericyte-like cells in glioblastoma promote the differentiation of monocytes into immunosuppressive tumor-associated macrophages.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine